Clinical Trial Update: Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. Placebo [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and efficacy of Phenazopyridine hydrochloride 200 mg vs placebo in urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Phenazopyridine hydrochloride (phenazopyridine hydrochloride)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Pain, Urinary Tract Infections | Phase 3 | Status: COMPLETED